Navamedic ASA: Q2 and first half 2022 financial results
Oslo, 12 August 2022 - Navamedic ASA (OSE: NAVA), a Nordic pharma company and reliable provider of high-quality products to hospitals and pharmacies, grew revenues by 67.2 percent in Q2 2022 compared to the same period in 2021 to NOK 110.4 million, driven by growth in the company’s key business areas. Navamedic reiterates its mid- to long-term ambition of building a NOK 1 billion company.“We are pleased to report record-high revenues and continued strengthening of our profits and cash flow in the second quarter. This was a result of strong growth across several key products, particularly